Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 0.610% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cn1nc(C(F)(F)F)c(-c2ccc(Br)cc2)c1NC(=O)c1cccnc1
b) Cn1c(N2CCN(S(=O)(=O)c3ccc(Cl)cc3)CC2)nc2ccccc21
Answer: a. Cn1nc(C(F)(F)F)c(-c2ccc(Br)cc2)c1NC(=O)c1cccnc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1nc(C(F)(F)F)c(-c2ccc(Br)cc2)c1NC(=O)c1cccnc1
Cn1nc(C(F)(F)F)c(-c2ccc(Br)cc2)c1NC(=O)c1cccnc1
N-[4-(4-bromophenyl)-2-methyl-5-(trifluoromethyl)pyrazol-3-yl]pyridine-3-carboxamide